Search - tctmd.com

Displaying 561 - 580 of 1571

Sort: Relevancy | Date

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

Presenter: Bahira Shahim

September 18, 2022

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

Presentation TCT 2022

TCT 184: Impact of Coronary Calcification in Patients Presenting with Acute Coronary Syndromes: Insights from the MATRIX trial

Presenter: Jorge Sanz Sanchez

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Presenter: Rachel Pathimagaraj

September 18, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Presentation TCT 2022

TCT 176: Randomized comparison of intracoronary lithotripsy and rotational atherectomy for the treatment of severely calcified vessels – ROTA.shock trial

Presenter: Holger Nef

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2022

TCT 286: Rates of Percutaneous Coronary Revascularization in Morphological- vs Functional-Guided Arms of the INTERCLIMA (Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria Identified by OCT in Patients With ACS) Randomized…

Presenter: Francesco Prati

September 17, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Presentation TCT 2022

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound…

Presenter: Piotr Musialek

September 17, 2022

Presentation TCT 2022

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

Presenter: Steven Messe

September 17, 2022

Presentation TCT 2022

TCT 283: Impact of Plaque Morphology on Invasive Coronary Physiology and Pressure Wire Discordance - Preliminary Results from the iEquate Trial.

Presenter: Avedis Ekmejian

September 17, 2022

Advertisement

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

TCT 184: Impact of Coronary Calcification in Patients Presenting with Acute Coronary Syndromes: Insights from the MATRIX trial

Ongoing Clinical Trials and the Future of LAAC

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

TCT 176: Randomized comparison of intracoronary lithotripsy and rotational atherectomy for the treatment of severely calcified vessels – ROTA.shock trial

Recent Clinical Trials & Registries: Update 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

TCT 286: Rates of Percutaneous Coronary Revascularization in Morphological- vs Functional-Guided Arms of the INTERCLIMA (Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria Identified by OCT in Patients With ACS) Randomized…

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound…

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

TCT 283: Impact of Plaque Morphology on Invasive Coronary Physiology and Pressure Wire Discordance - Preliminary Results from the iEquate Trial.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content